Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 15, Issue 7, 2013, Pages 544-549

  Cohen, Neale D ^a   Hong, Eui S ^b   Van Drie, Christy ^c   Balkau, Beverley ^a,d,e   Shaw, Jonathan ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b Cheongju St Mary's Hospital   (South Korea)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO;

ADULT; ARTICLE; BLOOD GLUCOSE METER; BODY MASS; BODY WEIGHT; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; BLOOD GLUCOSE; COHORT STUDIES; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; RETROSPECTIVE STUDIES; VICTORIA;

EID: 84880274658     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0331     Document Type: Article

References (18)

1. Pickup J, Mattock M, Kerry S: Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: Meta-Analysis of randomised controlled trials. BMJ 2002; 324:705
2. Pickup JC, Renard E: Long-Acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes. Diabetes Care 2008;31(Suppl 2):S140-S145
3. Pickup JC, Sutton AJ: Severe hypoglycaemia and glycaemic control in Type 1 diabetes: Meta-Analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008;25:765-774
4. Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV: A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004;27:1554-1558
5. Fahlen M, Eliasson B, Oden A: Optimization of basal insulin delivery in Type 1 diabetes: A retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine. Diabet Med 2005;22:382-386
6. Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, Santiago OM, Kolaczynski JW: Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care, 2005; 28:533-538
7. Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A: In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med 2008;25:326-332
8. Bott U, Jörgens V, Grüsser M, Bender R, Mühlhauser I, Berger M: Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabet Med 1994;11:362-371
9. Göbl CS, Dobes B, Luger A, Bischof MG, Krebs M: Long-Term impact of a structured group-based inpatienteducation program for intensive insulin therapy in patients with diabetes mellitus. Wien Klin Wochenschr 2010;122: 341-345
10. DAFNE Study Group: Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose Adjustment for Normal Eating (DAFNE) randomised controlled trial. BMJ 2002;325:746
11. Jakisch BI, Wagner VM, Heidtmann B, Lepler R, Holterhus PM, Kapellen TM, Vogel C, Rosenbauer J, Holl RW; German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy: Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: A multicentre matched-pair cohort analysis over 3 years. Diabet Med 2008.25:80-85
12. Alemzadeh R, Ellis JN, Holzum MK, Parton EA, Wyatt DT: Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes. Pediatrics 2004;114:e91-e95
13. Gunn D, Mansell P: Glycaemic control and weight 7 years after Dose Adjustment For Normal Eating (DAFNE) structured education in type 1 diabetes. Diabet Med 2012;29: 807-812
14. McIntyre HD, Knight BA, Harvey DM, NoudMN, Hagger VL, Gilshenan KS: Dose Adjustment For Normal Eating (DAFNE) -An audit of outcomes. Med J Aust 2010;192:637-640
15. Speight J, Amiel SA, Bradley C, Heller S, Oliver L, Roberts S, Rogers H, Taylor C, Thompson G: Long-Term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment For Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled type 1 diabetes. Diabetes Res Clin Pract 2010;89:22-29
16. Hopkins D, Lawrence I, Mansell P, Thompson G, Amiel S, Campbell M, Heller S: Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: The U.K. DAFNE experience. Diabetes Care 2012;35:1638-1642
17. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997;46:271-286
18. Lin CH, Huang CH, Tsai JS, Hsieh SH, Sun JH, Huang BY, Huang MJ, Huang YY: Effects of a novel short-Term continuous subcutaneous insulin infusion program evaluated by continuous glucose monitoring on young adult type 1 diabetic patients in Taiwan. Endocr J 2011;58:835-840